Fig. 1From: Efficacy and safety of Infliximab in systemic sarcoidosis according to GenPhenReSa organ-involvement phenotype: a retrospective study of 55 patientsStudy flow chart. MTX, methotrexate; CR, complete response; PR, partial responseBack to article page